Connecting Drug Delivery141

Issue No #141 Dec 2022 December 13th, 2022

Issue 141 - Dec 2022

Inside the magazine

DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE

Florian Krummenacher

DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE

Florian Krummenacher and Philippe Müller discuss the effectiveness of combining connected injection devices with digital solutions to drive therapy outcomes.

CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY

João Budzinski

CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY

João Budzinski discusses the benefits of connected drug delivery devices and the importance of cybersecurity when developing them, including the threats, key considerations and potential solutions.

PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT

PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT

Mark Tunkel and Cécile Gross consider the development of connected drug delivery devices and identify how understanding the patient journey from diagnosis to treatment can be used as an early-stage decision-making tool.

BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS

Benjamin D’hont

BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS

Benjamin D’hont and Joe Reynolds discuss how the key to maturing the digital health market and increasing user retention of digital health apps is integrating agile app development from the beginning of a therapeutic’s development cycle.

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Jabil Healthcare

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.

ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER

Edgar Hernan Cuevas Brun

HCmed Innovations

ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER

Edgar Hernan Cuevas Brun and Yuan-Ming Hsu consider patient adherence and the role HCmed Innovations’ AdheResp mesh nebuliser plays in monitoring adherence.

DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS

Dr Haykel Ben Jamaa

DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS

Haykel Ben Jamaa explores why modern society needs digital health and how it is organised and implemented, with a focus on sensing technologies empowering digital health technologies.

AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT

AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT

Michael Earl identifies areas of development in the field of connected drug delivery devices, providing an insight into what can be expected in the coming years. He draws on Owen Mumford’s own research, as well as discussions with industry experts and counterparts.

COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?

Amanda Whitcroft

Vivera Pharmaceuticals

COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?

Few technology companies reach unicorn status. US medtech company Vivera is hoping to be the next one, with its innovative approach to prescription drug delivery that aims to increase patient adherence and stop prescription drug abuse.

Top